Age-related appearance of dendritic inclusions in catecholaminergic brainstem neurons

Neurobiology of Aging

Volumn 34, Issue 1, 2013, Pages 286-297

  Braak, Heiko ^a   Thal, Dietmar Rudolf ^a   Matschke, Jakob ^b   Ghebremedhin, Estifanos ^a,c   Del Tredici, Kelly ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

synuclein; Aging; Catecholamines; Locus coeruleus; Marinesco bodies; P62; Sequestosome ubiquitin proteasomal pathway; Substantia nigra; Tau

Indexed keywords

ALPHA SYNUCLEIN; NEUROMELANIN; PROTEIN P62; TAU PROTEIN; TYROSINE 3 MONOOXYGENASE; UBIQUITIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN STEM; CATECHOLAMINE NERVE CELL; CELL GRANULE; CELL INCLUSION; CELL STRUCTURE; CELL TYPE; CHILD; CONTROLLED STUDY; DENDRITE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; NERVE PROJECTION; PERIKARYON; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PHOSPHORYLATION; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; ALPHA-SYNUCLEIN; BRAIN STEM; CATECHOLAMINES; CHILD; DENDRITES; FEMALE; HUMANS; INCLUSION BODIES; MALE; MIDDLE AGED; NEURONS; RNA-BINDING PROTEINS; YOUNG ADULT;

EID: 84868095485     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2012.02.031     Document Type: Article

References (73)

1. Alladi P.A., Mahadevan A., Vijayalakshmi K., Muthane U., Shankar S.K., Raju T.R. Ageing enhances alpha-synuclein, ubiquitin and endoplasmic reticular stress protein expression in the nigral neurons of Asian indians. Neurochem. Int 2010, 57:530-539.
2. Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, American Psychiatric Association, Washington, D.C.
3. Anderton B.H. Changes in the ageing brain in health and disease. Philos. Trans. R. Soc. Lond. B Biol. Sci 1997, 352:1781-1792.
4. Anderton B.H. Ageing of the brain. Mech. Ageing Dev 2002, 123:811-817.
5. Arai T., Nonaka T., Hasegawa M., Akiyama H., Yoshida M., Hashizume Y., Tsuchiya K., Oda T., Ikeda K. Neuronal and glial inclusions in frontotemporal dementia with or without motor neuron disease are immunopositive for p62. Neurosci. Lett 2003, 342:41-44.
6. Beach T.G., Walker D.G., Sue L.I., Newell A., Adler C.C., Joyce J.N. Substantia nigra Marinesco bodies are associated with decreased striatal expression of dopaminergic markers. J. Neuropathol. Exp. Neurol 2004, 63:329-337.
7. Benavides S.H., Monserrat A.J., Fariña S., Porta E.A. Sequential histochemical studies of neuronal lipofuscin in human cerebral cortex from the first to the ninth decade of life. Arch. Gerontol. Geriatr 2002, 34:219-231.
8. Bogerts B. A brainstem atlas of catecholaminergic neurons in man, using melanin as a natural marker. J. Comp. Neurol 1981, 197:63-80.
9. Braak H. Architectonics as seen by lipofuscin stains. Cerebral Cortex. Cellular Components of the Cerebral Cortex 1984, Vol I:59-104. Plenum Press, New York, London. E.G. Jones, A. Peters (Eds.).
10. Braak H., Alafuzoff I., Arzberger T., Kretzschmar H., Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 2006, 112:389-404.
11. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991, 82:239-259.
12. Braak H., Del Tredici K. Invited article: nervous system pathology in sporadic Parkinson's disease. Neurology 2008, 70:1916-1925.
13. Braak H., Del Tredici K. The pathological process underlying Alzheimer's disease in individuals under thirty. Acta Neuropathol 2011, 121:171-181.
14. Braak H., Del Tredici K., Rüb U., De Vos R.A.I., Jansen Steur E.N.H., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 2003, 24:197-210.
15. Braak H., Rüb U., Del Tredici K. Involvement of precerebellar nuclei in multiple system atrophy. Neurobiol. Appl. Neuropathol 2003, 29:60-76.
16. Braak H., Sastre M., Bohl J.R., de Vos R.A., Del Tredici K. Parkinson's disease: Lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathol 2007, 113:421-429.
17. Braak H., Thal D.R., Del Tredici K. Nerve cells immunoreactive for p62 in select hypothalamic and brainstem nuclei of controls and Parkinson's disease cases. J. Neural Transm 2011, 118:809-819.
18. Brunk U.T., Terman A. Lipofuscin: mechanisms of age-related accumulation and influence on cell function. Free Radic. Biol. Med 2002, 33:611-619.
19. Dickson D.W., Braak H., Duda J.E., Duyckaerts C., Gasser T., Halliday G.M., Hardy J., Leverenz J.B., Del Tredici K., Wszolek Z.K., Litvan I. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol 2009, 8:1150-1157.
20. Dickson D.W., Crystal H.A., Mattiace L.A., Masur D.M., Blau A.D., Davies P., Yen S.H., Aronson M.K. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol. Aging 1991, 13:179-189.
21. Dickson D.W., Fujishiro H., DelleDonne A., Menke J., Ahmed Z., Klos K.J., Josephs K.A., Frigerio R., Burnett M., Parisi J.E., Ahlskog J.E. Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease. Acta Neuropathol 2008, 115:437-444.
22. Dickson D.W., Wertkin A., Kress Y., Ksiezak-Reding H., Yen S.H. Ubiquitin immunoreactive structures in normal human brains. Distribution and developmental aspectss. Lab. Invest 1990, 63:87-99.
23. Double K.L., Dedov V.N., Fedorow H., Kettle E., Halliday G.M., Garner B., Brunk U.T. The comparative biology of neuromelanin and lipofuscin in the human brain. Cell. Mol. Life Sci 2008, 65:1669-1682.
24. Driscoll J. The role of the proteasome in cellular protein degradation. Histol. Histopathol 1994, 9:197-202.
25. Dwork A.J., Liu D., Kaufman M.A., Prohovnik I. Archival, formalin-fixed tissue: its use in the study of Alzheimer's type changes. Clin. Neuropathol 1998, 17:45-49.
26. Gal J., Ström A.L., Kilty R., Zhang F., Zhu H. p62 accumulates and enhances aggregate formation in model systems of familial amyotrophic lateral sclerosis. J. Biol. Chem 2007, 282:11068-11077.
27. Gal J., Ström A.L., Kwinter D.M., Kilty R., Zhang J., Shi P., Fu W., Wooten M.W., Zhu H. Sequestosome 1/p62 links familial ALS mutant SOD1 to LC3 via an ubiquitin-independent mechanism. J. Neurochem 2009, 111:1062-1073.
28. Gelb D.J., Oliver E., Gilman S. Diagnostic criteria for Parkinson disease. Arch. Neurol 1999, 56:33-39.
29. Gray D.A., Tsirigotis M., Woulfe J. Ubiquitin, proteasomes, and the aging brain. Sci. Aging Knowledge Environ 2003, 2003:RE6.
30. Gray D.A., Woulfe J. Lipofuscin and aging: a matter of toxic waste. Sci. Aging Knowledge Environ 2005, 2005:RE1.
31. Halliday G.M., Fedorow H., Rickert C.H., Gerlach M., Riederer P., Double K.L. Evidence for specific phases in the development of human neuromelanin. J. Neural Transm 2006, 113:721-728.
32. Hof P.R., Glannakopoulos P., Bouras C. The neuropathological changes associated with normal brain aging. Histol. Histopathol 1996, 11:1075-1088.
33. Hughes C.P., Berg L., Danziger W.L., Coben L.A., Martin R.L. A new clinical scale for the staging of dementia. Br. J. Psychiatry 1982, 140:566-572.
34. Kanaan N.M., Kordower J.H., Collier T.J. Age-related accumulation of Marinesco bodies and lipofuscin in rhesus monkey midbrain dopamine neurons: relevance to selective neuronal vulnerability. J. Comp. Neurol 2007, 502:683-700.
35. Keller J.N., Dimayuga E., Chen Q., Thorpe J., Gee J., Ding Q. Autophagy, proteasomes, lipofuscin, and oxidative stress in the aging brain. Int. J. Biochem. Cell Biol 2004, 36:2376-2391.
36. Klosen P., Maessen X., van den Bosch de Aguilar P. PEG embedding for immunocytochemistry: application to the analysis of immunoreactivity loss during histological processing. J. Histochem. Cytochem 1993, 41:455-463.
37. Komatsu M., Ichimura Y. Physiological significance of selective degradation of p62 by autophagy. FEBS Lett 2010, 584:1374-1378.
38. Korolchuk V.I., Menzies F.M., Rubinsztein D.C. A novel link between autophagy and the ubiquitin-proteasome system. Autophagy 2009, 5:862-863.
39. Kuusisto E., Kauppinen T., Alafuzoff I. Use of p62/SQSTM1 antibodies for neuropathological diagnosis. Neuropathol. Appl. Neurobiol 2008, 34:169-180.
40. Kuusisto E., Parkkinen L., Alafuzoff I. Morphogenesis of Lewy bodies: dissimilar incorporation of alpha-synuclein, ubiquitin, and p62. J. Neuropathol. Exp. Neurol 2003, 62:1241-1253.
41. Kuusisto E., Salminen A., Alafuzoff I. Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies. Neuroreport 2001, 12:2085-2090.
42. Kuusisto E., Salminen A., Alafuzoff I. Early accumulation of p62 in neurofibrillary tangles in Alzheimer's disease: possible role in tangle formation. Neuropathol. Appl. Neurobiol 2002, 28:228-237.
43. Layfield R., Searle M.S. Disruption of ubiquitin-mediated processes in diseases of the brain and bone. Biochem. Soc. Trans 2008, 36:469-471.
44. McKeith I.G., Dickson D.W., Lowe J., et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005, 65. 1863-1862.
45. Mizuno Y., Amari M., Takatama M., Aizawa H., Mihara B., Okamoto K. Immunoreactivities of p62, an ubiquitin-binding protein, in the spinal anterior horn cells of patients with amyotrophic lateral sclerosis. J. Neurol. Sci 2006, 249:13-18.
46. Moscat J., Diaz-Meco M.T., Wooten M.W. Signal intensification and diversification through the p62 scaffold protein. Trends Biochem. Sci 2007, 32:93-100.
47. Mrak R.E., Griffin S.T., Graham D.I. Aging-associated changes in human brain. J. Neuropathol. Exp. Neurol 1997, 56:1269-1275.
48. Nagaoka U., Kim K., Jana N.R., Doi H., Maruyama M., Mitsui K., Oyama F., Nukina N. Increased expression of p62 in expanded polyglutamine-expressing cells and its association with polyglutamine inclusions. J. Neurochem 2004, 91:57-68.
49. Olanow C.W., McNaught K.S. Ubiquitin-proteasome system and Parkinson's disease. Mov. Disord 2006, 21:1806-1823.
50. Pan T., Kondo S., Le W., Jankovic J. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease. Brain 2008, 131:1969-1978.
51. Pappolla M.A., Omar R., Saran B. The "normal" brain. "Abnormal" ubiquitinilated deposits highlight an age-related protein change. Am. J. Pathol 1989, 135:585-591.
52. Pikkarainen M., Martikainen P., Alafuzoff I. The effect of prolonged fixation time on immunohistochemical staining of common neurodegenerative disease markers. J. Neuropathol. Appl. Neurol 2010, 69:40-52.
53. Porta E.A. Pigments in aging: an overview. Ann. N. Y. Acad. Sci 2002, 959:57-65.
54. Price J.L., McKeel D.W., Buckles V.D., Roe C.M., Xiong C., Grundman M., Hansen L.A., Petersen R.C., Parisi J.E., Dickson D.W., Smith C.D., Davis D.G., Schmitt F.A., Markesbery W.R., Kaye J., Kurlan R., Hulette C., Kurland B.F., Higdon R., Kukull W., Morris J.C. Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol. Aging 2009, 30:1026-1036.
55. Román G.C., Tatemichi T.K., Erkinjuntti T., Cummings J.L., Masdeu J.C., Garcia J.H., Amaducci L., Orgogozo J.M., Brun A., Hofman A., et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993, 43:250-260.
56. Sandmann-Keil D., Braak H., Okochi M., Haass C., Braak E. Alpha-synuclein immunoreactive Lewy bodies and Lewy neurites in Parkinson's disease are detectable by an advanced silver-staining technique. Acta Neuropathol 1999, 98:461-464.
57. Saper C., Petito C. Correspondence of melanin-pigmented neurons in human brain with A1-A14 catecholamine cell groups. Brain Res 1982, 105:87-101.
58. Schwab C., Yu S., McGeer P.L. Optineurin is colocalized with ubiquitin in Marinesco bodies. Acta Neuropathol 2012, 123:289-292.
59. Scott I.S., Lowe J.S. The ubiquitin-binding protein p62 identifies argyrophilic grain pathology with greater sensitivity than conventional silver stains. Acta Neuropathol 2007, 113:417-420.
60. Seibenhener M.L., Babu J.R., Geetha T., Wong H.C., Krishna N.R., Wooten M.W. Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. Mol. Cell. Biol 2004, 24:8055-8068.
61. Seibenhener M.L., Geetha T., Wooten M.W. Sequestosome 1/p62-more than just a scaffold. FEBS Lett 2007, 581:175-179.
62. Shin J. p62 and the sequestosome, a novel mechanism for protein metabolism. Arch. Pharm. Res 1998, 21:629-633.
63. Smithson K.G., MacVicar B.A., Hatton G.I. Polyethylene glycol embedding: a technique compatible with immunocytochemistry, enzyme histochemistry, histofluorescence and intracellular staining. J. Neurosci. Methods 1983, 7:27-41.
64. Terman A., Brunk U.T. Lipofuscin. Int. J. Biochem. Cell Biol 2004, 36:1400-1404.
65. Terman A., Gustafsson B., Brunk U.T. Autophagy, organelles and ageing. J. Pathol 2007, 211:134-143.
66. Terman A., Kurz T., Navratil M., Arriaga E.A., Brunk U.T. Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging. Antioxid. Redox Signal 2010, 12:503-535.
67. Thal D.R., Rüb U., Schultz C., Sassin I., Ghebremedhin E., Del Tredici K., Braak E., Braak H. Sequence of Abeta-protein deposition in the human medial temporal lobe. J. Neuropathol. Exp. Neurol 2000, 59:733-748.
68. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer. Neurobiol. Aging 1997, 18:S1-S2. The National Institute on Aging.
69. Wooten M.W., Hu X., Babu J.R., Seibenhener M.I., Geetha T., Paine M.G., Wooten M.C. Signaling, polyubiquitination, trafficking, and inclusions: sequestosome 1/p62's role in neurodegenerative disease. J. Biomed. Biotechnol 2006, 2006:1-12.
70. Yuen P., Baxter D.W. The morphology of Marinesco bodies (paranucleolar corpuscles) in the melanin-pigmented nuclei of the brain-stem. J. Neurol. Neurosurg. Psychiatry 1963, 26:178-183.
71. Zecca L., Tampellini D., Gerlach M., Riederer P., Fariello R.G., Sulzer D. Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour. J. Clin. Pathol. Mol. Pathol 2001, 54:414-418.
72. Zecca L., Zucca F.A., Albertini A., Rizzio E., Fariello R.G. A proposed dual role of neuromelanin in the pathogenesis of Parkinson's disease. Neurology 2006, 67(7 suppl 2):S8-S11.
73. Zecca L., Zucca F.A., Wilms H., Sulzer D. Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics. Trends Neurosci 2003, 26:578-580.